Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 9 posts of 894 posts found.

Pfizer sets out on $17 billion acquisition trail

July 21, 2006
Sales and Marketing Pfizer

Pfizer, the world's biggest pharmaceutical company, has earmarked $17 billion to spend on new products and technologies over the next …

News

Biotech buy helps Pfizer expand neuroscience research

April 26, 2006
Research and Development, Sales and Marketing Pfizer

Pfizer is to buy Californian Rinat Neuroscience, a biotech company which specialises in developing therapeutic proteins to treat central nervous …

News

Pfizer to go it alone with Exubera

January 16, 2006
Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin

 Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …

News

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005
Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …

News

Pharma continues to invest in UK research and development

October 24, 2005
Sales and Marketing Pfizer, R&D

 UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …

News

Industry braced for new upheaval in primary care

September 8, 2005
Sales and Marketing NHS, PCTs, Pfizer

 Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …

News

Pfizer pulls out of Daxas collaboration

July 7, 2005
Sales and Marketing Daxas, Nycomed, Pfizer

Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …

News

Pfizer UK recruiting for new customer-focused salesforce

July 8, 2004
NHS, Pfizer, salesforce

 Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …

News

A tale of two pills for Pfizer in Q1

April 26, 2004
Pfizer, torceptrapib

 The first quarter of 2004 saw Pfizer’s biggest seller Lipitor extend its domination of the statin market but Viagra, another …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026